MEK5-ERK5 inhibitors target chronic myeloid leukemia stem cells and in combination with imatinib reduce the expression of stem cell genes. (July 2016) - Tusa, I.; Cheloni, G.; Gray, N.S.; Gozzini, A.; Sbarba, P. Dello; Rovida, E.